about
Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancerSphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis CIntractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gainA New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε).Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption.Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy.Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.Analysis of glycero-lysophospholipids in gastric cancerous ascites.Identification and biochemical characterization of a novel autotaxin isoform, ATXδ, with a four-amino acid deletion.Decrease in circulating autotaxin by oral administration of prednisolone.Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.[Significance of serum autotaxin activity in gastrointestinal disease].Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma.Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.Role of the Autotaxin-LPA Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells.Performance of autotaxin as a serum marker for liver fibrosis.Plasma levels of natriuretic peptides and year-by-year blood pressure variability: a population-based study.Serum autotaxin measurements in pregnant women: application for the differentiation of normal pregnancy and pregnancy-induced hypertension.Autotaxin as a novel serum marker of liver fibrosis.Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma.Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis CPast history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antiviralsENPP2 Contributes to Adipose Tissue Expansion and Insulin Resistance in Diet-Induced ObesityClinical Introduction of Lysophosphatidic Acid (LPA) and Autotaxin AssaysSerum Autotaxin is not a Useful Biomarker for Ovarian CancerA novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A1 in human serum samplesAutotaxin enzyme immunoassay in human cerebrospinal fluid samplesAnti-idiotypic monoclonal antibody recognizes a consensus recognition site for phosphatidylserine in phosphatidylserine-specific monoclonal antibody and protein kinase CLysophospholipids in laboratory medicine.Production and characterization of monoclonal antibodies that specifically bind to phosphatidylcholine
P50
Q24658328-4BFAE727-2556-4721-8F04-94385F0FA30CQ33405952-500A6088-8D1C-4FDB-BE50-146546EA2E3FQ33582978-149A86B6-D973-4F74-838A-FEE283D6AF5DQ33929416-89DC6338-B597-499A-A052-732F510752D0Q34449570-37476E26-A723-444C-B37A-662F7CE5115EQ35034900-4EF46C99-BD8A-41F2-B246-55A17F31FBD3Q35665934-F2B9F536-F0F8-4976-BFE6-7A16E5FBB434Q39185609-F94B58D3-9958-49A4-B479-D5A1AAD7D46AQ40938355-B46D041C-1FE5-4F83-BCD1-914163D22AB7Q42135026-91B878A0-BCB4-4A13-B676-28ECF9600679Q42278873-8213EC35-8758-4E84-B3C1-A852D9A6AA84Q42620134-34FD376B-61FD-41F4-9A95-0A3422DBCCF0Q44195997-9EB1C783-4CE6-4F99-85D4-5115E73720BAQ45325150-EF5A0F7A-2BE4-4F43-995A-E1F4B16542E4Q45971516-C14582DE-2421-495A-A112-3F82F53283BFQ46424226-089861AE-9547-4669-9C89-9C70EA65E179Q46441367-1E23CAC2-5228-4D06-B75F-CFE73BD5CBD8Q46929180-C12E5269-A1C2-49CF-8385-72A6F9369954Q47228463-617EF4F5-F1A7-4C2B-84AD-EE4140B4B6B1Q47601933-AEE16D5E-AAC9-492C-82DB-6948A5B080B7Q50865807-C3601B23-FAEF-4B71-B5FA-2A8FCE410CC5Q51435820-46582A72-9A8F-4725-8D07-0672F4E0659CQ51490124-202CCDB3-D8A3-40E9-B7EA-5E337FC0D93DQ52676188-39BF59D7-653B-4454-B059-576ADA63C13CQ52952320-BA2616EB-0767-4D6B-8F13-DAAA3B322289Q54242128-3D653BB5-84ED-467F-A538-B55A4642C7CDQ54967305-AD541303-D804-4C73-8ED5-C71AB93A43F8Q55009231-CA77FD25-AB6C-432C-9104-3FD2ACEDD356Q55220563-EA02962C-4CDF-4495-A927-C27491472924Q57152789-5BFD7665-5390-4992-87FA-85C0B125A885Q58711401-2EA3616E-5726-4AA1-85D5-118B2FD6EDBCQ59356040-82282DFC-1C99-4872-8D77-5959DBAF5215Q59939712-24D4A86F-1011-4489-AA5F-A45705591441Q59939716-392BE69E-CCBA-4909-A98B-DE94C35C0727Q59939722-C791C971-7BF9-4931-8E51-5F36ABBAFA50Q59939730-72CB6436-9D41-4991-A029-AFFB7BFACDD2Q59939732-3BE44277-831E-4A30-AD60-4CD99ADC3305Q59939767-8E5ABAEF-E6C7-4E8F-A475-C831DDF0D554Q64884687-EE2C3BAE-625A-4265-A1DC-C2A653A246B1Q67669919-42F6FCED-4D4A-43DD-8BB1-0416AB17E4BD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Koji Igarashi
@ast
Koji Igarashi
@en
Koji Igarashi
@es
Koji Igarashi
@nl
Koji Igarashi
@sl
type
label
Koji Igarashi
@ast
Koji Igarashi
@en
Koji Igarashi
@es
Koji Igarashi
@nl
Koji Igarashi
@sl
prefLabel
Koji Igarashi
@ast
Koji Igarashi
@en
Koji Igarashi
@es
Koji Igarashi
@nl
Koji Igarashi
@sl
P106
P108
P1153
55367035000
P31
P496
0000-0002-5007-7079